Orion
Kari-Pekka Mäkelä has extensive experience in risk management, corporate development, and mergers and acquisitions, primarily at Orion Corporation, where roles have included Director of Risk Management and Corporate Development, Director of Business Planning and Analytics, and Director of Mergers & Acquisitions. Responsibilities have encompassed risk management support, corporate strategy, business planning, valuation, and integration planning across multiple business areas. Prior experience includes positions at Pharmaservice Oy and Orion Pharma, alongside management roles at Gemini Consulting, Orion-Farmos, and Wartsila Diesel. Kari-Pekka holds a Master of Science in Industrial Management from Teknillinen korkeakoulu and has completed various executive education programs at leading institutions, including the University of St. Gallen and London Business School.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.